862. Lefamulin
Session: Symposium: New Antibiotics: What's in the Pipeline
Thursday, October 5, 2017: 2:45 PM
Room: 20ABCD
Steven P. Gelone, PharmD, Nabriva Therapeutics US, Inc., King of Prussia, PA


Disclosures:

S. P. Gelone, Nabriva Therapeutics: Employee and Shareholder , Salary

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.